Also trades as: CERO (OTC) · $vol 0M
CEROW OTC
CERo Therapeutics Holdings, Inc.
1W: -45.1%
1M: +94.5%
3M: -71.5%
YTD: -57.2%
1Y: -88.0%
$0.00
+0.00 (+18.89%)
Weekly Expected Move ±256.2%
$-0
$-0
$0
$0
$0
Overview
News
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Dividends
Analysis
Technicals
Weather
Peers
ESG
Institutions
Dark Pool
Short Interest
Supply Chain
Smart Money Score
No convergence signal
Key Statistics
Market Cap$0.0M
52W Range0.0011-0.0285
Volume1,000
Avg Volume45,420
Beta0.16
Dividend—
Analyst Ratings
No analyst coverage
Company Info
CEOChristopher Ehrlich
Employees8
SectorHealthcare
IndustryBiotechnology
IPO Date2024-02-14
Websitecero.bio
201 Haskins Way
South San Francisco, CA 94080
US
South San Francisco, CA 94080
US
650-407-2376
About CERo Therapeutics Holdings, Inc.
CERo Therapeutics Holdings, Inc. operates as an immunotherapy firm, concentrating its efforts on developing cutting-edge engineered T-cell therapies designed to combat cancer. Its primary therapeutic initiative addresses blood cancers, specifically by aiming to counteract a particular "Eat Me" signaling mechanism that is significantly overexpressed on both B-cell and myeloid tumor cells. The company's corporate headquarters are situated in South San Francisco, California.
Latest News
No recent news
Recent Insider Trades
| Name | Type | Shares | Price | Date |
|---|---|---|---|---|
| Francois Eric | 0 | — | 2026-02-13 | |
| Patel Shami | 0 | — | 2024-10-11 | |
| Patel Shami | 0 | — | 2024-10-11 | |
| KUCHARCHUK ANDREW AL | 0 | — | 2024-10-01 | |
| Pierce Kristen | 0 | — | 2024-10-01 |